Mushrooms Inc. (MSRM)
OTC PINK OTC PINK Primary 
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Treatment-Resistant Depression (TRD) stands as one of the most stubborn and costly challenges in modern healthcare. For the millions of patients who have cycled through multiple antidepressants without relief, the treatment landscape has long been a graveyard of failed promises.
Mushrooms, Inc. (OTC: MSRM) Signs Share Exchange Agreement to Acquire SecurCapital Corp
ESTERO, Fla., Jan. 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Mushrooms, Inc. (OTC: MSRM), a U.S.
Announcing Adaptin - Bringing Mushrooms to the Masses
PROVO, UT / ACCESSWIRE / June 25, 2024 / Announcing the launch of Adaptin, a new wellness brand extending the benefits of functional adaptogens and nootropics to consumers globally through new marketing pathways. The new company brings innovation to both the formulations and the way products are shared in the growing adaptogen and functional mushroom dietary supplements, valued in the US at USD $40B in 2023, and a part of the rapidly growing USD $5.7T global wellness market.
